Acknowledgements.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2009, v. 2, n. 6, p. 413, doi. 10.1177/1756285609353674
- Publication type:
- Article
Works matching IS 17562856 AND DT 2009 AND VI 2 AND IP 6
Results: 7
1
2
Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2009, v. 2, n. 6, p. 357, doi. 10.1177/1756285609344375
- By:
- Publication type:
- Article
3
Benefit of repetitive intrathecal triamcinolone acetonide therapy in predominantly spinal multiple sclerosis: prediction by upper spinal cord atrophy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2009, v. 2, n. 6, p. 349, doi. 10.1177/1756285609343480
- By:
- Publication type:
- Article
4
Review: Improving symptom control in early Parkinson’s disease.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2009, v. 2, n. 6, p. 393, doi. 10.1177/1756285609339383
- By:
- Publication type:
- Article
5
Review: Deep brain stimulation in Parkinson’s disease.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2009, v. 2, n. 6, p. 379, doi. 10.1177/1756285609339382
- By:
- Publication type:
- Article
6
Review: Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy: challenges for the future.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2009, v. 2, n. 6, p. 369, doi. 10.1177/1756285609337976
- By:
- Publication type:
- Article
7
Review: Pathophysiology and treatment of bacterial meningitis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2009, v. 2, n. 6, p. 401, doi. 10.1177/1756285609337975
- By:
- Publication type:
- Article